Intratympanic steroid injection for treating sudden sensorineural hearing loss in patients with hepatitis B virus infection
ITSIs are effective in managing SSNHL in patients with HBV while minimizing the side effects associated with high-dose systemic steroids. Among the 77 HBV patients with SSNHL who received ITSI, age ≥ 50 years and profound hearing loss were identified as negative prognostic factors. For HBV patients with these risk factors, timely and proactive treatment is essential.
Authors
- Chia-Ying Ho
- Yu-Chien Wang
- Shih-Lung Chen (ORCID: https://orcid.org/0000-0003-4051-4009)
- Shy-Chyi Chin
- Kai‐Chieh Chan (ORCID: https://orcid.org/0000-0003-1372-0229)
Institutions
- Chang Gung University (TW)
- Chang Gung Memorial Hospital (TW)
- Taipei Municipal YangMing Hospital (TW)
- Taoyuan Chang Gung Memorial Hospital (TW)
- Keelung Chang Gung Memorial Hospital (TW)
- Linkou Chang Gung Memorial Hospital (TW)
Publication Details
- Journal
- American Journal of Otolaryngology
- Published
- 2025-04-26
- DOI
- https://doi.org/10.1016/j.amjoto.2025.104660
- Citations
- 1
- Primary Topic
- Vestibular and auditory disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.84